Drug Shortage Report for MOZOBIL
Report ID | 125088 |
Drug Identification Number | 02377225 |
Brand name | MOZOBIL |
Common or Proper name | Mozobil |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | PLERIXAFOR |
Strength(s) | 20MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 1 x 2.0ml |
ATC code | L03AX |
ATC description | IMMUNOSTIMULANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2020-12-04 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | 2020-11-25 |
Shortage status | Avoided shortage |
Updated date | 2020-11-25 |
Company comments | production/ supply delay - Considering the exceptional circumstances, the remaining stock will be distributed on allocation with a limit of 2 vials per order. Pharmacies are invited to communicate with their preferred distributor to obtain more information on product availability. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.